Minister of Health witnesses the launch of a national network to enhance AI-based tumour diagnosis, “Digital Pathology”.
His Excellency Prof. Dr. Khaled Abdel Ghaffar, Minister of Health and Population, witnessed the signing of a memorandum of understanding between the Ministry of Health and Roche Diagnostics to launch the National Digital Pathology Network in Egypt, at the Egyptian Center for Disease Control (EGYCDC), with the aim of strengthening national diagnostic capacities, accelerating tumour diagnosis and raising the accuracy of results in hospitals and healthcare units.
The memorandum was signed on behalf of the ministry by Prof. Dr. Mohamed Hassany, Assistant Minister for Public Health Projects and Initiatives, and on behalf of the company by Eng. Moataz Nassef, Chairman of the Board of Roche Diagnostics Egypt, in the presence of ministry leaders and representatives of the presidential initiatives.
His Excellency the Minister affirmed that the launch of the network represents a decisive strategic step in the transformation of the health system towards precision medicine and digital diagnosis, and reflects the state’s commitment to building a modern health system that places the citizen at the heart of its priorities, noting that the network forms the cornerstone of an integrated digital infrastructure nationwide, going beyond a technical upgrade to become a fundamental pillar for developing diagnosis and treatment. He explained that the network eliminates the barrier of geographical distance and ensures accurate and rapid diagnosis that may save patients’ lives, describing it as the strategic brain of modern oncology services in Egypt, as it spreads excellence and achieves equity in access to advanced medicine for all citizens.
His Excellency the Minister noted that the first phase starts from seven strategic sites, including centres in Cairo, Ain Shams, Sohag, Kafr El-Sheikh and Damanhour, reducing the distance between patients and experts.
The Minister highlighted the success of the Women’s Health Initiative in reducing the period from suspicion of the disease to the start of treatment, with an improvement rate of 82%, affirming that converting samples into digital images supported by artificial intelligence will raise diagnostic accuracy to 92%, with the new technology able to detect 5% of cases that the human eye may miss, while the rate of early detection at the first and second stages has risen from 34% to 70%.
His Excellency the Minister highlighted the strength of the public-private partnership as a model of integration between the state’s vision and technological innovation, seeking to set a new regional benchmark that strengthens Egypt’s position as a centre of excellence in the Middle East and Africa. For his part, Eng. Moataz Nassef affirmed the commitment of “Roche” to developing genomic solutions and building sustainable capacities.
Thomas Baumgartner, Deputy Head of Mission at the Embassy of Switzerland, praised the agreement as evidence of the depth of Egyptian-Swiss cooperation in health innovation. Following the signing, the Minister toured the laboratories to see the artificial intelligence algorithms that enable specialists to assess tissue slides with high accuracy and objectivity.